id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-E-0283-0002,FDA,FDA-2002-E-0283,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2003-11-24T05:00:00Z,2003,11,,,2025-10-16T23:53:47Z,,0,0,090000648049ea9b
FDA-2002-E-0283-0001,FDA,FDA-2002-E-0283,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOMETA,Notice,General Notice,2003-03-05T05:00:00Z,2003,3,,,2025-09-30T17:55:20Z,03-4691,0,0,090000648049ea26